Founded in 2023, Sola Spectra was built on a single conviction: that Saudi Arabia’s hospitals and clinics deserve direct access to the world’s best healthcare products — without compromise, without intermediaries, and without one-size-fits-all solutions.
In less than two years, we grew from zero to SAR 5 million in annual revenue, became the #1 dental whitening supplier to Saudi MOH clinics, and built partnerships with manufacturers across Germany, the USA, South Korea, and beyond.
Get in Touch →
30+ years of global healthcare experience across local and international markets. A strategic thinker with a business-minded, results-oriented approach. Leads consulting and overall company direction.
“Start with the end in mind, see the big picture — winning is a team effort.”
25 years in dental sales and marketing. A renowned name in the Saudi dental community who chose business over clinical practice, rising to CEO level within the Saudi dental industry. Leads the dental division and drives our flagship fläsh product.
Sola Spectra established with a mission to bridge global healthcare innovation with Saudi market needs. First agreements signed with WHITEsmile GmbH (Germany) for fläsh dental whitening.
fläsh becomes the standard of care at Saudi Ministry of Health dental clinics. Contracts secured with KSU and KAU dental schools.
fläsh surpasses SAR 4 million in sales in under three quarters — establishing Sola Spectra as Saudi Arabia’s #1 whitening supplier.
Revenue hits SAR 5 million — 12.5× growth from year one. Medical device and software divisions launched. Offices in Jeddah and Dammam opened.
Local manufacturing for fläsh products, AI healthcare analytics platform launch, and expansion to support 25+ global manufacturers entering Saudi Arabia.
Every product, software, and service is built for the Kingdom’s regulatory environment, Arabic language, and clinical workflows — not adapted from international templates.
We partner only with manufacturers whose products meet the highest global standards. SFDA registration, clinical evidence, and real-world outcomes are non-negotiable.
We invest in training, after-sales support, and continuous improvement alongside every client and manufacturer partner.